Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects

Edo Kon, Nitay Ad‐El, Inbal Hazan‐Halevy, Lior Stotsky‐Oterin, Dan Peer

View at source ↗PDF ↗Review376 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1038/s41571-023-00811-9
Published
Aug 16, 2023
Venue
Nature Reviews Clinical Oncology
DOI
10.1038/s41571-023-00811-9
PubMed
37587254
Categories
RNA Interference and Gene Delivery
License
other-oa
Provenance
openalex

Topics